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A new paradigm for primary prevention strategy in people with elevated risk
of stroke
Valery L. Feigin1* and Bo Norrving2
Existing methods of primary stroke prevention are not
sufficiently effective. Based on the recently developed
Stroke Riskometer app, a new ‘mass-elevated risk stroke/
cardiovascular disease prevention’ approach as an addition to
the currently adopted absolute risk stroke/cardiovascular
disease prevention approach is being advocated. We believe
this approach is far more appealing to the individuals con-
cerned and could be as efficient as the conventional
population-based approach because it allows identification
and engagement in prevention of all individuals who are at an
increased (even slightly increased) risk of stroke and cardio-
vascular disease. The key novelty of this approach is twofold.
First, it utilizes modern far-reaching mobile technologies,
allowing individuals to calculate their absolute risk of stroke
within the next 5 to 10 years and to compare their risk with
those of the same age and gender without risk factors.
Second, it employs self-management strategies to engage
the person concerned in stroke/cardiovascular disease
prevention, which is tailored to the person’s individual risk
profile. Preventative strategies similar to the Stroke Riskome-
ter could be developed for other non-communicable disorders
for which reliable predictive models and preventative recom-
mendations exist. This would help reduce the burden of non-
communicable disorders worldwide.
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The most recent Global Burden of Disease 2010 estimates (1)
showed that the global burden of stroke continues to increase,
with 16·9 million of people being affected by stroke annually,
resulting in over 100 million disability-adjusted life years lost.
There is also a worrisome global trend showing an increase in the
number of strokes in young and middle-aged adults by 25%
between 1990 and 2010 (2). This epidemic of stroke can and
should be stopped and reversed (3), as over 90% of strokes are
potentially avoidable (4). While management strategies for
primary stroke prevention in high cardiovascular disease (CVD)
risk individuals [including stroke and transient ischemic attack
(TIA)] are well established (5), they are underutilized (5–7), and
existing methods of primary stroke prevention are not sufficiently
effective (8,9). The health care system has so far been largely
unsuccessful in providing meaningful information to assist
people to adhere to recommended lifestyle and medications
(5,9,10). Uptake of this information is particularly low in people
with moderately increased risk of stroke who would benefit from
lifestyle changes (9,11). Inadequate CVD risk factor management
(9) is implicated in underutilization of evidence-based primary
stroke prevention strategies in those with moderately increased
risk of stroke (12).
It is generally accepted that to be effective, primary stroke pre-
vention should include both community-wide and high-risk pre-
ventative strategies. While community-wide efforts to reduce the
prevalence and improve control of major modifiable risk factors
for stroke (e.g. salt intake reduction, smoking cessation, blood
pressure control) are the most cost-effective strategies for stroke
prevention at a population level (3,13), they often require legis-
lative changes and continuous educational campaigns. Currently
used by health professionals, high-risk preventative strategies are
aimed at the identification and management of people with high
risk of stroke (e.g. people with elevated blood pressure, dyslipi-
demia, carotid artery stenosis). However, one of the main prob-
lems with this high-risk stroke prevention strategy is that it misses
out most of the people who later develop a stroke because in
reality most strokes are happening in people with only a mild
increased risk of CVD (14,15). In addition, people with only a
mildly elevated risk of CVD often do not seek medical attention
and, therefore, it is difficult to include them in stroke prevention
interventions. Currently available CVD risk assessment algo-
rithms (16–18) allow calculation of absolute risk of CVD (includ-
ing stroke), but they are designed for use by health professionals.
Yet, one of the main challenges in effective stroke prevention on
an individual level is the lack of awareness about stroke symptoms
and risk factors as well as self-managing strategies to reduce their
risk of stroke.
The question is how to improve stroke prevention in individu-
als with an increased CVD risk in the most efficient way? We
recently developed an app called Stroke Riskometer (19) that has
the potential to significantly improve stroke and CVD prevention
on an individual level. Based on the Framingham Heart Study
stroke prediction algorithm (17) and enhanced to include seven
additional major risk factors important for stroke (diet, physical
activity, waist-to-hip ratio, alcohol, psychosocial stress, family
history of stroke or heart attack, race/ethnicity), this user-friendly
Stroke Riskometer is able to provide an estimate of the individu-
al’s absolute risk of stroke within the next 5 and 10 years for
anyone from the age of 20 up to 90+ years old. The importance of
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adding those seven risk factors for better stroke prediction has
been demonstrated in the recent INTERSTROKE study (4).
Importantly, the Stroke Riskometer user can find out not only
their absolute risk of stroke development but also a baseline risk
to compare their risk against, thus allowing them to know their
risk of stroke compared with someone of their age and gender
who has no risk factors. The former represents a new paradigm
for high-risk stroke prevention strategy, which is distinctly differ-
ent from the traditional threshold-based approach in which
people are categorized into low, moderate, and high-risk groups
(20). However, the threshold-based high-risk approach is for use
by health professionals and is less appealing to the individuals
concerned because it does not tell them at what particular risk of
CVD/stroke they are compared with people of the same age and
gender but without any additional risk factors. For example, a
woman of 35 years old who has a family history of stroke (her
father had a stroke at the age of 64),eats less than six servings of
fruits and/or vegetables a day, has experienced significant mental
or emotional stress (permanent or several periods) over the last
year, has a systolic blood pressure reading of 128 mmHg, and has
an absolute risk of stroke within the next 5 years of 0·15%.
Although her absolute risk is relatively low, her relative risk of
stroke is roughly 1·7 times greater than someone of her age and
gender who has no contributing risk factors (0·09%), and this is
likely to be perceived by the woman as the significant stimulus to
reduce her risk of having a stroke. However, if we base our esti-
mates on one of the threshold-based CVD risk charts (21), the
woman’s risk falls into a mild CVD risk category, which seems to
be far less of a motivation for her to reduce her risk of stroke. This
represents a new application of the basic underlying idea of
targeting the whole population instead of a high-risk group for
primary prevention (so-called ‘prevention paradox’ concept) first
introduced by the epidemiologist Geoffrey Rose in 1981 (14). The
key novelty of this approach is twofold. First, it utilizes modern
far-reaching technologies [global mobile Internet subscriptions is
expected to reach 4·5 billion by the end of 2018, with the mobile
phone remaining the most frequently used access device (http://
www.ericsson.com/ericsson-mobility-report accessed date 17
March 2014)], allowing huge number of individuals across the
globe to calculate their absolute risk of stroke within the next 5 to
10 years and to compare their risk with those of the same age and
gender without risk factors. Second, it employs self-management
strategies to engage the person concerned in stroke/CVD preven-
tion, which is tailored to the person’s individual risk profile.
However, whether this smartphone-based high-risk strategy on a
population level is effective in changing people’s behavior and
improving stroke prevention remains to be proven, and we are
planning an international clinical trial to test this hypothesis.
Current feedback from over 5300 Stroke Riskometer app users is
encouraging, and the app is being validated against the Framing-
ham stroke prediction algorithm.
There are also other important features of the Stroke Riskome-
ter to improve stroke prevention. For example, people can change
details they enter in the Stroke Riskometer to visually observe the
effect of changes in their risk of having a stroke. The Stroke
Riskometer can also be used to estimate a risk of recurrent stroke
by people who have already experienced a stroke or TIA and to
calculate their risk of having a heart attack within the next 5 and
10 years. It can also be used for monitoring progress of stroke and
heart attack prevention. The app (version 1) is available as a free
Fig. 1 Some snapshots of the Stroke Riskometer App screens from some smartphones and iPad.
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download for iPhone, iPad [https://itunes.apple.com/nz/app/
stroke-riskometer/id725335272?mt=8 (access date 17 March
2014)], Android tablets, and other smartphone users [https://
play .google . com/store / search?q=stroke%20riskometer&hl=en
(access date 17 March 2014)] (Fig. 1). The World Stroke Organi-
zation has endorsed the free version of the Stroke Riskometer
[http: / /www.world-stroke .org/education/stroke-riskometer
(access date 17 March 2014)]. In addition, a premium version of
the Stroke Riskometer app (Stroke Riskometer Pro) contains
audio-visual educational information about stroke and stroke
prevention and provides recommendations from experts on how
to manage risk factors based on a person’s stroke risk profile to
reduce the risk of having a stroke or heart attack. The self-
management of stroke and CVD risk factors is also a new and
appealing approach in preventative medicine (22,23). All the edu-
cation information and recommendations are based on interna-
tionally recognized primary stroke prevention guidelines (5).
Tailoring the recommendations to a particular person and pre-
senting them in a self-management format is likely to improve the
uptake of this educational information. It is expected that the
self-management, individual risk profile-oriented recommenda-
tions together with the educational and stroke risk self-
assessment tool will empower a user to take control of and
improve their stroke prevention. The increased utilization of
modern mobile technologies such as smartphones provides a
unique opportunity to introduce new prevention strategies to
those at elevated risk of stroke or CVD (there are currently 1
billion smartphone users in the world and this number is pro-
jected to increase to 1·4 billion by the end of 2013). Although this
is a new ‘mass-elevated risk stroke/CVD prevention’ approach to
stroke/CVD prevention at an individual level, it is important to
note that the Stroke Riskometer is not designed to be a replace-
ment for seeking professional medical advice, but rather an edu-
cational self-management tool that allows users to identify if they
fall into a risk category and take preventive measures to protect
against future strokes. Therefore, the Stroke Riskometer app
should be considered as an addition to the currently adopted
absolute stroke/CVD prevention approach. It should also be
noted that estimates based on the Stroke Riskometer app may not
be generalizable to a global audience, and further research should
be carried out to validate and improve accuracy of the stroke
prediction algorithm for different populations in different
countries.
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